Treatment of scleroderma.
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D062365:Aminobenzoates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D062365:Aminobenzoates; D010129:4-Aminobenzoic Acid